Lightning Talk and Exhibitor Opportunity, Organized by MIT Media Lab with contributions from MIT Startup Exchange and Takeda Pharmaceuticals
Katharine Sepp, Co-founder & CEO, Oxalys Pharmaceuticals
Bringing the Power of Medicinal Chemistry to Protein Therapies
A leading pharmaceutical company in Amyotrophic Lateral Sclerosis (ALS) is interested in speaking with startups whose technology could contribute to very early diagnosis of the disease.
Introduced by Marcus Dahllof, Associate Program Director, MIT Startup Exchange; Cliff Reid, PhD, CEO, Travera; Todd Gierahn, PhD, Cofounder, Honeycomb; Laura Indolfi, PhD, CEO & Cofounder, PanTher Therapeutics; Ulrik Nielsen, PhD, CEO & Cofounder, Torque; Jason Norris, Cofounder, Elektrofi; Patrick Stern, PhD, CEO & Founder, Sextant; Carlos Castro-Gonzalez, PhD, CEO & Cofounder, Leuko Labs; and Alec Nielsen, PhD, Cofounder, Asimov.
Early-stage backers of Rivian, JIMCO seeks MIT spin-off startups that are initiating or improving commercialization efforts across multiple industries - eg. energy, water, mobility.
P&G is looking for new technology-enabled solutions, services and business models that incentivize and drive lasting behavior change.